Literature DB >> 8821911

Maroteaux-Lamy syndrome associated with growth hormone deficiency.

B Büyükgebiz1, Y Eroğlu, I Kovanlikaya, A Sen, A Büyükgebiz.   

Abstract

Growth retardation is a common feature of mucopolysaccharide storage disorders, mostly considered to be a consequence of skeletal changes, Maroteaux-Lamy disease is a subtype of mucopolysaccharidosis, demonstrating somatic changes and skeletal deformities. We present a case with Maroteaux-Lamy disease associated with growth hormone deficiency. Magnetic resonance imaging study revealed marked signal changes in white matter due to the storage in brain and empty sella appearance in sellar region. In the presence of empty sella syndrome, hypothalamic-pituitary dysfunction due to the storage material may have led to growth hormone deficiency in this patient. Therefore, we recommend patients with mucopolysaccharidosis, especially those who have growth retardation, to be evaluated by hormonal and radiological studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821911     DOI: 10.1515/jpem.1995.8.4.305

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

Review 1.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 2.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

3.  Growth Charts for Individuals with Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome).

Authors:  Adrian Quartel; Christian J Hendriksz; Rossella Parini; Sue Graham; Ping Lin; Paul Harmatz
Journal:  JIMD Rep       Date:  2014-12-18

4.  Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.

Authors:  Celeste Decker; Zi-Fan Yu; Roberto Giugliani; Ida Vanessa D Schwartz; Nathalie Guffon; Elisa Leão Teles; M Clara Sá Miranda; J Edmond Wraith; Michael Beck; Laila Arash; Maurizio Scarpa; David Ketteridge; John J Hopwood; Barbara Plecko; Robert Steiner; Chester B Whitley; Paige Kaplan; Stuart J Swiedler; Susan Conrad; Paul Harmatz
Journal:  J Pediatr Rehabil Med       Date:  2010

Review 5.  Mucopolysaccharidoses: overview of neuroimaging manifestations.

Authors:  Manal Nicolas-Jilwan; Moeenaldeen AlSayed
Journal:  Pediatr Radiol       Date:  2018-05-11

6.  Anterior Hypopituitarism and Treatment Response in Hunter Syndrome: A Comparison of Two Patients.

Authors:  Munier A Nour; Paola Luca; David Stephure; Xing-Chang Wei; Aneal Khan
Journal:  Case Rep Pediatr       Date:  2016-11-28

7.  Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI: 10-Year follow up.

Authors:  Mahoko Furujo; Motomichi Kosuga; Torayuki Okuyama
Journal:  Mol Genet Metab Rep       Date:  2017-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.